학술논문

CT radiomics can predict disease progression within 6 months after chimeric antigen receptor-modified T-cell therapy in relapsed/refractory B-cell non-Hodgkin's lymphoma patients
Document Type
Article
Source
In Clinical Radiology October 2023 78(10):e707-e717
Subject
Language
ISSN
0009-9260